company background image
IART

Integra LifeSciences Holdings NasdaqGS:IART Stock Report

Last Price

US$54.57

Market Cap

US$4.6b

7D

-2.9%

1Y

-23.0%

Updated

18 Aug, 2022

Data

Company Financials +
IART fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance1/6
Financial Health3/6
Dividends0/6

IART Stock Overview

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.

Integra LifeSciences Holdings Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Integra LifeSciences Holdings
Historical stock prices
Current Share PriceUS$54.57
52 Week HighUS$76.70
52 Week LowUS$51.21
Beta1.09
1 Month Change0.092%
3 Month Change-8.90%
1 Year Change-22.96%
3 Year Change-11.30%
5 Year Change9.14%
Change since IPO1,079.89%

Recent News & Updates

Aug 16

Integra LifeSciences founder/former CEO dies

Integra LifeSciences (NASDAQ:IART) said its Founder and Former Chairman and CEO Richard Caruso died during the weekend. Caruso served as chairman from 1992 to 2011, and as CEO from 1992 to 1997.

Shareholder Returns

IARTUS Medical EquipmentUS Market
7D-2.9%-0.4%1.4%
1Y-23.0%-21.3%-8.4%

Return vs Industry: IART underperformed the US Medical Equipment industry which returned -21.1% over the past year.

Return vs Market: IART underperformed the US Market which returned -9% over the past year.

Price Volatility

Is IART's price volatile compared to industry and market?
IART volatility
IART Average Weekly Movement4.1%
Medical Equipment Industry Average Movement9.5%
Market Average Movement7.6%
10% most volatile stocks in US Market17.1%
10% least volatile stocks in US Market3.1%

Stable Share Price: IART is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: IART's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19893,800Jan De Wittehttps://www.integralife.com

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services.

Integra LifeSciences Holdings Corporation Fundamentals Summary

How do Integra LifeSciences Holdings's earnings and revenue compare to its market cap?
IART fundamental statistics
Market CapUS$4.56b
Earnings (TTM)US$166.30m
Revenue (TTM)US$1.57b

27.4x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IART income statement (TTM)
RevenueUS$1.57b
Cost of RevenueUS$570.60m
Gross ProfitUS$996.24m
Other ExpensesUS$829.94m
EarningsUS$166.30m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.99
Gross Margin63.58%
Net Profit Margin10.61%
Debt/Equity Ratio93.4%

How did IART perform over the long term?

See historical performance and comparison